IRIS
GALLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.567
AS - Asia 4.000
NA - Nord America 3.474
SA - Sud America 792
AF - Africa 59
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 18.905
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 6.759
US - Stati Uniti d'America 3.408
SG - Singapore 1.443
IT - Italia 1.146
IE - Irlanda 1.008
CN - Cina 949
BR - Brasile 668
HK - Hong Kong 609
GB - Regno Unito 361
DE - Germania 322
UA - Ucraina 283
VN - Vietnam 245
KR - Corea 219
JP - Giappone 161
SE - Svezia 137
AT - Austria 133
IN - India 128
TR - Turchia 113
FI - Finlandia 100
FR - Francia 92
GR - Grecia 70
AR - Argentina 52
NL - Olanda 49
CA - Canada 29
BE - Belgio 23
BD - Bangladesh 21
MX - Messico 20
EC - Ecuador 19
IQ - Iraq 18
MA - Marocco 17
PY - Paraguay 16
ES - Italia 15
CO - Colombia 14
ID - Indonesia 13
CZ - Repubblica Ceca 11
IR - Iran 11
PK - Pakistan 11
PL - Polonia 10
UZ - Uzbekistan 10
ZA - Sudafrica 10
KE - Kenya 9
AU - Australia 8
UY - Uruguay 8
CH - Svizzera 6
DZ - Algeria 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
EG - Egitto 5
IL - Israele 5
LT - Lituania 5
RO - Romania 5
AZ - Azerbaigian 4
CL - Cile 4
DO - Repubblica Dominicana 4
RS - Serbia 4
SA - Arabia Saudita 4
TN - Tunisia 4
TW - Taiwan 4
AM - Armenia 3
CR - Costa Rica 3
ET - Etiopia 3
EU - Europa 3
JO - Giordania 3
LV - Lettonia 3
NI - Nicaragua 3
PE - Perù 3
AL - Albania 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CY - Cipro 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
AQ - Antartide 1
BB - Barbados 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
Totale 18.900
Salva come PNG Salva come JPEG
Città #
Moscow 2.328
Dublin 1.006
Singapore 612
Hong Kong 609
Santa Clara 595
Jacksonville 448
Chandler 387
Seoul 215
Hefei 182
Naples 161
Princeton 129
Beijing 122
Vienna 117
Caserta 114
Ann Arbor 113
Roxbury 105
New York 103
Bengaluru 98
Medford 94
The Dalles 89
Ho Chi Minh City 88
Ashburn 85
Bremen 62
São Paulo 61
Wilmington 60
Munich 59
Dallas 56
Woodbridge 55
Boardman 53
Rome 50
Hanoi 49
Nanjing 46
Milan 44
Norwalk 42
San Mateo 40
Cambridge 39
Los Angeles 37
Napoli 32
Nuremberg 27
Des Moines 26
Brussels 23
London 23
Quarto 21
Aversa 20
Jinan 20
Falkenstein 19
Tokyo 17
Shenyang 16
Mountain View 15
Rio de Janeiro 14
Turku 14
Belo Horizonte 13
Brooklyn 13
Haiphong 13
Houston 13
Istanbul 13
Verona 13
Curitiba 12
Stockholm 12
Turin 12
Genoa 11
Guangzhou 11
Guarulhos 11
Redwood City 11
Reggio Emilia 11
San Francisco 11
Shanghai 11
Thái Bình 11
Auburn Hills 10
Brasília 10
Caivano 10
Campinas 10
Ercolano 10
Guayaquil 10
Helsinki 10
Lappeenranta 10
Montreal 10
Amsterdam 9
Chicago 9
São José do Rio Preto 9
Tashkent 9
Tianjin 9
Atlanta 8
Baghdad 8
Düsseldorf 8
Falls Church 8
Florence 8
Nairobi 8
Phoenix 8
Belém 7
Cercola 7
Hải Dương 7
Kunming 7
Lanzhou 7
Ribeirão Preto 7
Sala Consilina 7
Salvador 7
Asunción 6
Bologna 6
Casablanca 6
Totale 9.307
Salva come PNG Salva come JPEG
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 644
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 186
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 185
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 184
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 184
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 171
Advantages of QBI in TBSS analyses. 169
Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis 164
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 161
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 158
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 158
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 157
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 152
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 150
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 150
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 150
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 149
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 146
Frontotemporal cortical thinning in amyotrophic lateral sclerosis. 142
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 142
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 142
Assessing response to interferon-β in a multicenter dataset of patients with MS 141
A multiparametric brain and cord MR imaging study of a patient with Hirayama disease. 138
A Combined Use of Radiomics and Connectomics to Classify Sex and Age in Healthy Subjects: The New “Radioconnectomics” Paradigm 137
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 137
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis. 136
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod 132
T(1) cortical hypointensities and their association with cognitive disability in multiple sclerosis 132
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis 132
Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study 131
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 130
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 130
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 129
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 129
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 128
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 126
Quality of life in women with multiple sclerosis and overactive bladder syndrome 126
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 125
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 125
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 125
An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS 124
Extra-motor involvement in ALS patients: a cortical thickeness 3T MRI study 124
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 124
The role of diet in multiple sclerosis: A review 123
Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study 122
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 121
Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis 120
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy. 120
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab 120
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 118
Epidemiologic Data of Vitamin D Deficiency and Its Implication in Cardio-Cerebrovascular Risk in a Southern Italian Population 117
Proton spectroscopic imaging - Principles and clinical applications in neurology 117
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 117
Informing MS patients on treatment options: a consensus on the process of consent taking 117
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 116
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 116
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 115
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 115
Consensus of algorithms for lesion segmentation in brain MRI studies of multiple sclerosis 114
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 114
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 114
A real-world study of alemtuzumab in a cohort of Italian patients 114
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter Study 113
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 112
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 112
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence 111
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 111
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution 111
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 111
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 110
dVRS and Fatigue: is there a link? Magnetic Resonance retrospective 3T study 110
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study. 109
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 108
Vocabulary knowledge as a reliable proxy of cognitive reserve in multiple sclerosis: a validation study 108
Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype 108
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 108
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years 107
Multiparametric MRI in a patient with adult-onset leukoencephalopathy with vanishing white matter 107
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI 106
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 106
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study 106
Functional gradients reveal cortical hierarchy changes in multiple sclerosis 105
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 105
Signs and symptoms of COVID-19 in patients with multiple sclerosis 104
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 104
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. 104
Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients 104
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs 103
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity 103
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis 102
Post-contrast MRI in multiple sclerosis: Towards a judicious use of gadolinium-based contrast agents 102
Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy. 101
Quality and Quantity of Diffuse and Focal White Matter Disease and Cognitive Disability of Patients with Multiple Sclerosis 101
Malattie del Sistema nervoso Autonomo 101
Functional plasticity of the visual system in multiple sclerosis. 99
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: A MAGNIMS Study 98
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 98
The Relationships Between Cognitive Reserve and Psychological Symptoms: A Cross-Sectional Study in Healthy Individuals 98
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability 98
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis. 97
Totale 12.936
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021445 0 0 0 0 0 16 121 87 17 81 93 30
2021/2022945 53 15 19 35 287 27 25 40 61 65 70 248
2022/20231.778 179 22 32 127 166 132 6 85 941 27 26 35
2023/20241.058 71 38 53 105 262 120 69 29 36 21 107 147
2024/20253.086 22 33 43 91 553 369 414 230 465 369 282 215
2025/20269.981 505 752 706 626 1.054 6.338 0 0 0 0 0 0
Totale 19.379